Abstract
Neurofibromatosis is a collective name for a group of genetic conditions in which benign tumours affect the nervous system. Type 1 is caused by a genetic mutation in the NF1 gene (OMIM 613113) and symptoms can vary dramatically between individuals, even within the same family. Some people have very mild skin changes, whereas others suffer severe medical complications. The condition usually appears in childhood and is diagnosed if two of the following are present: six or more café-au-lait patches larger than 1.5 cm in diameter, axillary or groin freckling, 2 or more Lisch nodules (small pigmented areas in the iris of the eye), 2 or more neurofibromas, optic pathway gliomas, bone dysplasia, and a first-degree family relative with Neurofibromatosis type 1. The pattern of inheritance is autosomal dominant, however, half of all NF1 cases are ‘sporadic’ and there is no family history. Neurofibromatosis type 1 is an extremely variable condition whose morbidity and mortality is largely dictated by the occurrence of the many complications that may involve any of the body systems. We describe a family affected by NF1 in whom genetic molecular analysis identified the same mutation in the son and father. Routine MRI showed pontine focal lesions in the eight-year-old son, though not in the father. We performed a four years follow-up study and at follow-up pontine hamartoma size remained unchanged in the son, and the father showed still no brain lesions, confirming thus an intra-familial phenotype variability.
Highlights
Neurofibromatosis type 1 (NF1) (OMIM#162200) [1] has a prevalence of 1 in 4,000 individuals in the general population
The family we describe confirms that a father and son with the same NF1 genetic defects may not present the same clinical picture, confirming the possible occurrence of an intra-familial variability [1,2]
To date, contrasting literature data have been published on the usefulness and early predictive value of both diffusionweighted imaging (DWI) and MR spectroscopy (MRS) [7,10,11,12,13,14]
Summary
Neurofibromatosis type 1 (NF1) (OMIM#162200) [1] has a prevalence of 1 in 4,000 individuals in the general population. Routine MRI showed pontine focal lesions in the eight-year-old son, though not in the father. At follow-up, four years later pontine hamartoma size remained unchanged in the son, and the father showed still no brain lesions, confirming an intra-familial phenotype variability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.